Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Lixte Biotechnology Holdings ( (LIXT) ).
On August 13, 2025, LIXTE Biotechnology Holdings announced an update to its corporate treasury policy to include cryptocurrency, allowing up to 25% of its treasury to be allocated to digital assets like Bitcoin. This strategic move is aimed at hedging existing treasury assets and enhancing shareholder value, while ensuring all transactions comply with financial regulations.
More about Lixte Biotechnology Holdings
LIXTE Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company focused on developing new cancer therapies. The company is pioneering a new field of cancer biology called activation lethality and has a lead compound, LB-100, which is undergoing proof-of-concept clinical trials for various cancers.
Average Trading Volume: 2,100,872
Technical Sentiment Signal: Sell
Current Market Cap: $22.12M
Learn more about LIXT stock on TipRanks’ Stock Analysis page.